Containment & Isolation White Papers & Case Studies

1. Drastically Reduced Isolator Decontamination Cycles 2/28/2013

   With the use of catalytic aeration, M + P is able to reduce the duration of the aeration phase in isolators by about 50 %. The aeration phase is the most time consuming cycle during H2O2 decontamination. By Felix Henning, Optima Packaging Group GmbH 

2. Emerging Fourth Generation Pharmaceutical Containment Technologies 2/25/2013

   Barrier technology has become overwhelmingly accepted as the basis for new aseptic processing facilities in 2013. The traditional clean room facilities of the 20th century are being rapidly replaced with advanced barrier based technology filling facilities. This technological evolution is dramatically reducing the risk of product contamination and risk of infection to patients. By Sterling Kline, RA IPS

3. A High Volume Process For Highly Potent (HP) Active Pharmaceutical Ingredients (APIs) 2/20/2013

   This case study demonstrates how a commercial manufacturing partnership between Alkermes Contract Pharma Services (Alkermes) and a large pharmaceutical company resulted in the establishment of a high volume process for Highly Potent (HP) Active Pharmaceutical Ingredients (APIs).

4. High Containment For Potent Product Transfer 1/25/2013

   Achieving the desired containment of products during manufacturing is a careful combination of well-engineered equipment, expert process design, simplification of operations, and access to real-time feedback on existing procedures.

5. Determining The Right Glovebox For Accurate Level Of Containment 1/9/2013

   A Glovebox is a sealed enclosure that allows materials handling through long, relatively impermeable gloves secured to ports in the walls of the enclosure. The purpose is protection or isolation, which is provided by the physical barrier. Depending on the type of system, the physical barrier may be to isolate a sensitive material inside the box from environmental contamination (controlled atmosphere type) or to protect the operator from hazardous materials being manipulated inside the box (ventilated type). Most systems have a main chamber where manipulations occur and a smaller transfer or antechamber where samples, small apparatus, and supplies are introduced into the main chamber. By Gary Roepke and Bob Applequist, Labconco Corporation

6. Alternatives to Traditional Fume Hoods: Ductless Enclosures And Fume Hoods 12/20/2012

   Safety is the primary purpose of any filtered enclosure or ventilated fume hood. In most situations, fume hoods remain the equipment of choice for ventilating hazardous airborne chemicals from the laboratory. By Gary Roepke, Senior Project Engineer, Labconco Corporation

7. Laboratory Fume Hood Conflict "Energy Savings" vs "Safe Containment" 12/20/2012

   Safety is the primary purpose of any laboratory hood. Facility managers and laboratory planners desire fume hoods that can conserve energy without compromising safety. Exhausting less air through a hood can result in substantial energy savings.

8. The XPert Nano Enclosure's Ability To Contain Nanoparticles Is NANOSAFE TESTED™ 12/20/2012

   NANOSAFE INC., an independent testing company, evaluated the XPert Nano Enclosure for its ability to contain nanoparticles.

9. Robotics And Isolator-Barrier Systems: The Perfect Combination For Advanced Aseptic Processing 11/27/2012

   The aim of advanced aseptic processing is the elimination and absolute control of all sources of contaminants – most importantly, humangenerated contamination. By Joshua Russell

10. Biological Contamination Events In Isolators: What Lessons Can Be Learned? 8/17/2012

    Microbiological deviation and biological contamination events have been observed in pharmaceutical isolators including those used in production, sterility test and pharmacy aseptic services. By James Drinkwater, Bioquell UK Process & Compliance Director